Clinical partners

The greatest innovations come from collaboration, when clinics, universities and industry share knowledge, inspire each other and form partnerships to find new possibilities. RaySearch is committed to collaboration and knowledge sharing. We make a firm commitment to our partners, which includes a promise to ensure ongoing compatibility, for example by supporting hardware developments and new features into the future.


MedAustron (Austria)
MedAustron is a cutting-edge center for ion therapy and research, specialized in advanced cancer treatment using protons and carbon ions. The center is located in Wiener Neustadt, Lower Austria, around 50 km south of Vienna. MedAustron has been using RayStation for treatment planning since 2016. In early 2022, they will move to using RayCare and RayCommand for oncology information management and treatment delivery – managing the full patient journey using RaySearch products.


Heidelberg and Marburg, ION bean therapy centers (Germany)
These two prestigious sites in Germany are operational with proton and carbon ion therapy. Heidelberg University Hospital became a RayCare®* partner in 2018. RayStation®* was selected jointly by clinicians and researchers at HIT, MIT, Heidelberg University Hospital and the German Cancer Research Center. RayStation is the first commercial treatment planning system in the world to support helium ion therapy, and Heidelberg Hospital's Ion Beam Therapy Center is the first in Europe with helium, supported by RayStation. Heidelberg has used RayCare clinically since 2019 to drive and support their RayStation planning workflows.


Iridium Cancer Network (Belgium)
ICN represents the close collaboration between all seven hospitals in Antwerp, Belgium, and shares a radiation therapy department. ICN became a RaySearch partner in 2015 and was the first to use RayCare clinically, just two months after the clinical release of the system.


Swiss medical network.PNG.png

Swiss Medical Network, Switzerland)
Swiss Medical Network is one of Switzerland's two leading private clinic groups. Its clinics provide first-class hospital treatment, care and assistance for all three of the country's main language regions. Swiss Medical Network became a clinical partner of RaySearch in 2019 and has been using RayCare clinically since September 2020.



Provision Healthcare (USA)
Provision became a RayCare partner in 2017. In 2014, the Provision CARES Proton Therapy Center, Knoxville, became the first center in the world to use RayStation for clinical proton treatments. Provision are using only RaySearch products to manage all patient treatments including treatment session management with RayTreat since 2018, with 48 users, and 18550 fractions delivered. 


University Health Network (Canada)
UHN and RaySearch have enjoyed a successful and longstanding relationship via the Princess Margaret Cancer Centre, Toronto. In July 2018, we joined forces to further develop RayCare. Princess Margaret is one of the largest comprehensive cancer treatment facilities in the world. The center recently made a major expansion of its RayStation platform and is on the way to being one of the biggest RayStation installations in the world.


University Medical Center Groningen (Netherlands)
UMCG was the first in the country to provide proton radiation therapy in addition to advanced photon irradiation techniques. The clinic is equipped with IBA’s ProteusPLUS two-gantry room configuration, pencil-beam scanning, and cone-beam CT capabilities. UMCG has been instrumental in the development of oncology information system RayCare since 2015. UMCG has been instrumental in the development of oncology information system RayCare, and have been using RayCare clinically since 2019.


University of California, San Francisco (USA)
UCSF became a RaySearch partner in 2016. RayCare will support complex procedures and analyses at UCSF that are out of reach with current information management systems. An aim of the partnership is to develop a comprehensive approach to data infrastructure for clinical decision support. RayCare will enable UCSF to optimize resources and personalize patient care.


University of Texas MD Anderson Cancer Center (USA)
MD Anderson first began using RayStation in 2013 with conventional linear accelerators, later adding the TomoTherapy System and working closely with RaySearch and Accuray. The clinic now uses RayStation for all radiation treatment planning. RaySearch began collaboration in 2017 with the center to enable clinical implementation of RayCare in a complex and large-scale environment. By 2018, a strategic alliance was formed to enhance cancer radiation therapy through the utilization of adaptive radiation therapy (ART) and increase efficiency and automation of planning workflows.


University of Wisconsin-Madison (USA)
UWM became a RayCare partner in 2017. RayCare will support the department’s strong multidisciplinary approach to cancer care and its focus on cutting-edge techniques. The University, which has long tradition of radiation therapy treatment, has also implemented RayStation as its treatment planning system.


Yonsei Cancer Center (South Korea)
Established in 1969, Yonsei Cancer Center takes a leading role in developing new treatment approaches to eliminate cancer. The center, which is part of Yonsei University Health System (YUHS), has continuously invested to introduce state-of-the-art technology and new techniques to South Korea, providing tailored treatment regimens and giving hope to patients and caregivers.
Yonsei University Health System was founded in 1885 as the first modern medical institution in the country and is comprised of the following: Severance Hospital(including 5 specialized Hospitals, Heavy ion therapy Center, Severance Robot and MIS Center) and Dental Hospital in Sinchon, Seoul; Gangnam Severance Hospital in Gangnam area, located in the Southern part of Seoul (including 4 Specialized Hospitals) and 1 local hospitals in satellite cities near Seoul. The strong network between these institutions as well as their specialized medical services are what give Yonsei University Health System its invaluable strength


*Subject to regulatory clearance in some markets.